Medical Marijuana, Inc. Announces Historic Registration of its CBD Products in Paraguay as a Medicine

Tuesday, January 9, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Official Product Registration Makes Medical Marijuana, Inc. Cannabis Products First Available Through Medical Distribution Channels in Paraguay

SAN DIEGO, Jan. 9, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company

in the United States, today announced the historic registration of its Real Scientific Hemp Oil-X™ (RSHO-X™) and RSHO™-Blue Label products as registered medicines by Paraguay's national health regulation organization (Dirección Nacional de Vigilancia Sanitaria).

"We are a Company of firsts and we are excited about this new historic milestone of being the first company to have a CBD product registered in Paraguay," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

"We have actively pursued getting our pipeline of botanical cannabis products registered and approved as therapeutic products in countries around the world, which opens the ability for international pharmacies and healthcare providers to distribute cannabis products to patients," added Dr. Titus. "This is yet another example of the international trend of acceptance of CBD for therapeutic use, and we are continually encouraged by the decisions of governments and regulators to permit use of cannabis and CBD products for patients suffering from multiple indications - especially where conventional medicine has had modest or limited effects."

Paraguay's official registration of Medical Marijuana, Inc.'s CBD hemp oil products marks the first country that has registered and approved the Company's products as medicinal products. Currently, Medical Marijuana, Inc.'s CBD hemp oil products have been used in Paraguay with medical indications ranging from cancer, pain, multiple sclerosis, epilepsy and various other neurological diseases. 

Prior to becoming registered as official medicines, in May of 2016, Real Scientific Hemp Oil™ became the first medical cannabis product approved and imported for use in Paraguay for compassionate use with a prescription and government permission. This event marked the third time in a little over a year that RSHO™ was the first cannabis product approved in a Latin American country, following the lead of Brazil and Mexico.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. 888-829- 0070andrew.hard@cmwmedia.comwww.cmwmedia.com

 

Cision View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-announces-historic-registration-of-its-cbd-products-in-paraguay-as-a-medicine-300579642.html

SOURCE Medical Marijuana, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store